Skip to content

Menu

  • Home
  • About
    • Leadership
    • Science
    • Contact Me
  • Glyoxalase 1 inducer
    • Our Flagship Product
    • Glo1 inducer peer-reviewed publications
  • Protein glycation “AGEomics”
    • Quantitation of protein glycation
    • AGEomics technique
    • AGEomics Peer-Reviewed Publications
  • Partnering and consultancy
  • News
  • Blog

Uncategorized

You are here: | Blog | Uncategorized

2025 Paper on GlucoRegulate as a prospective treatment for early stage MASLD

Peer-reviewed paper on Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD)

user February 18, 2024November 19, 2025 Uncategorized No Comments Read more

2024 Paper on how GlucoRegulate may be an adjunct/standalone for incretin therapeutics

Peer-reviewed paper on “Unraveling the impaired incretin effect in obesity and type 2 diabetes: Key role of hyperglycemia-induced unscheduled glycolysis and glycolytic overload”

user February 18, 2024November 19, 2025 Uncategorized No Comments Read more

Recent Posts

  • 2025 Paper on GlucoRegulate as a prospective treatment for early stage MASLD
  • 2024 Paper on how GlucoRegulate may be an adjunct/standalone for incretin therapeutics

Categories

  • Uncategorized

Meta

  • Log in
  • Entries feed
  • Comments feed
  • WordPress.org

Contact Info

  • Director’s Office Glocentrica Ltd
  • Email: glocentrica@gmail.com
  • Website: glocentrica.com

Recent News

  • 2025 Paper on GlucoRegulate as a prospective treatment for early stage MASLD
  • 2024 Paper on how GlucoRegulate may be an adjunct/standalone for incretin therapeutics
Copyright © 2025 . All rights reserved. Theme Spacious by ThemeGrill. Powered by: WordPress.